JCAD can interact with large tumor suppressor kinase 2 (LATS2), thereby inhibiting the ability of LATS2 to phosphorylate yes-associated protein (YAP) in hepatoma cells in vitro [30]. The gene discussed is JCAD; the disease is hepatocellular carcinoma.